Top 10 i doser doses3/11/2024 ![]() The risks and benefits of treatment with ACTEMRA should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection. Bacterial, viral and other infections due to opportunistic pathogens.Patients with invasive fungal infections may present with disseminated, rather than localized, disease. ![]() Invasive fungal infections, including candidiasis, aspergillosis, and pneumocystis.Treatment for latent infection should be initiated prior to ACTEMRA use. Patients should be tested for latent tuberculosis before ACTEMRA use and during therapy. Active tuberculosis, which may present with pulmonary or extrapulmonary disease. ![]() If a serious infection develops, interrupt ACTEMRA until the infection is controlled. Patients treated with ACTEMRA are at increased risk for developing serious infections that may lead to hospitalization or death, including tuberculosis (TB), bacterial, invasive fungal, viral, or other opportunistic infections. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |